Cross Country Healthcare (CCRN)
Market Price (6/21/2026): $13.17 | Market Cap: $414.5 MilSector: Health Care | Industry: Health Care Facilities
Cross Country Healthcare (CCRN)
Market Price (6/21/2026): $13.17Market Cap: $414.5 MilSector: Health CareIndustry: Health Care Facilities
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -25% Attractive yieldFCF Yield is 9.6% Megatrend and thematic driversMegatrends include Healthcare Workforce Innovation, and Healthcare Talent & Labor Market Dynamics. Themes include Clinical Staffing Solutions, Integrated Workforce Management, Show more. | Weak multi-year price returns2Y Excs Rtn is -49%, 3Y Excs Rtn is -125% | Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -7.2 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -0.7% Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -20%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -27%, Rev Chg QQuarterly Revenue Change % is -18% Valuation getting more expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 67% Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -28% Key risksCCRN key risks include [1] a significant decline in demand for staffing services and [2] regulatory uncertainty surrounding its pending acquisition. |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -25% |
| Attractive yieldFCF Yield is 9.6% |
| Megatrend and thematic driversMegatrends include Healthcare Workforce Innovation, and Healthcare Talent & Labor Market Dynamics. Themes include Clinical Staffing Solutions, Integrated Workforce Management, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -49%, 3Y Excs Rtn is -125% |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -7.2 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -0.7% |
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -20%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -27%, Rev Chg QQuarterly Revenue Change % is -18% |
| Valuation getting more expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 67% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -28% |
| Key risksCCRN key risks include [1] a significant decline in demand for staffing services and [2] regulatory uncertainty surrounding its pending acquisition. |
Qualitative Assessment
AI Analysis | Feedback
Cross Country Healthcare (CCRN) stock has gained about 50% since 2/28/2026 because of the following key factors:
1. Cross Country Healthcare (CCRN) experienced a significant surge due to the announcement of its acquisition by KL Criss Cross Intermediate, LLC (Knox Lane) for $13.25 per share in an all-cash transaction valued at $437 million. This definitive merger agreement was announced around May 6-8, 2026, and provided a substantial premium, driving the stock price towards the acquisition value from its prior trading levels.
2. The stock received positive momentum from analyst upgrades in the period leading up to the acquisition announcement. Wedbush upgraded its rating for CCRN to "Outperform" on March 19, 2026, with a price target of $15. Similarly, Benchmark upgraded its rating to "Buy" on March 5, 2026. These upgrades likely contributed to increased investor confidence and buying interest.
Show more
Cross Country Healthcare (CCRN) stock has gained about 50% since 2/28/2026 because of the following key factors:
1. Cross Country Healthcare (CCRN) experienced a significant surge due to the announcement of its acquisition by KL Criss Cross Intermediate, LLC (Knox Lane) for $13.25 per share in an all-cash transaction valued at $437 million. This definitive merger agreement was announced around May 6-8, 2026, and provided a substantial premium, driving the stock price towards the acquisition value from its prior trading levels.
2. The stock received positive momentum from analyst upgrades in the period leading up to the acquisition announcement. Wedbush upgraded its rating for CCRN to "Outperform" on March 19, 2026, with a price target of $15. Similarly, Benchmark upgraded its rating to "Buy" on March 5, 2026. These upgrades likely contributed to increased investor confidence and buying interest.
3. Better-than-expected first-quarter 2026 earnings, despite year-over-year declines, offered some support to the stock. Cross Country Healthcare reported Q1 2026 revenue of $241.1 million, which, although down 17.8% year-over-year, surpassed the Zacks Consensus Estimate by 2.34%. The company's adjusted loss of $0.03 per share also beat the consensus estimate of a $0.05 loss per share. Furthermore, the company reported sequential revenue growth of 2% in Q1 2026.
Show less
Stock Movement Drivers
Fundamental Drivers
The 51.4% change in CCRN stock from 2/28/2026 to 6/20/2026 was primarily driven by a 64.8% change in the company's P/S Multiple.| (LTM values as of) | 2282026 | 6202026 | Change |
|---|---|---|---|
| Stock Price ($) | 8.70 | 13.17 | 51.4% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,127 | 1,002 | -11.1% |
| P/S Multiple | 0.3 | 0.4 | 64.8% |
| Shares Outstanding (Mil) | 33 | 31 | 3.3% |
| Cumulative Contribution | 51.4% |
Market Drivers
2/28/2026 to 6/20/2026| Return | Correlation | |
|---|---|---|
| CCRN | 51.4% | |
| Market (SPY) | 9.2% | -2.9% |
| Sector (XLV) | -6.4% | -9.9% |
Fundamental Drivers
The 28.4% change in CCRN stock from 11/30/2025 to 6/20/2026 was primarily driven by a 39.8% change in the company's P/S Multiple.| (LTM values as of) | 11302025 | 6202026 | Change |
|---|---|---|---|
| Stock Price ($) | 10.26 | 13.17 | 28.4% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,127 | 1,002 | -11.1% |
| P/S Multiple | 0.3 | 0.4 | 39.8% |
| Shares Outstanding (Mil) | 33 | 31 | 3.3% |
| Cumulative Contribution | 28.4% |
Market Drivers
11/30/2025 to 6/20/2026| Return | Correlation | |
|---|---|---|
| CCRN | 28.4% | |
| Market (SPY) | 9.9% | 6.4% |
| Sector (XLV) | -4.4% | -3.0% |
Fundamental Drivers
The -0.1% change in CCRN stock from 5/31/2025 to 6/20/2026 was primarily driven by a -20.4% change in the company's Total Revenues ($ Mil).| (LTM values as of) | 5312025 | 6202026 | Change |
|---|---|---|---|
| Stock Price ($) | 13.18 | 13.17 | -0.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,258 | 1,002 | -20.4% |
| P/S Multiple | 0.3 | 0.4 | 22.3% |
| Shares Outstanding (Mil) | 32 | 31 | 2.6% |
| Cumulative Contribution | -0.1% |
Market Drivers
5/31/2025 to 6/20/2026| Return | Correlation | |
|---|---|---|
| CCRN | -0.1% | |
| Market (SPY) | 28.1% | 14.7% |
| Sector (XLV) | 14.6% | 2.1% |
Fundamental Drivers
The -48.4% change in CCRN stock from 5/31/2023 to 6/20/2026 was primarily driven by a -62.0% change in the company's Total Revenues ($ Mil).| (LTM values as of) | 5312023 | 6202026 | Change |
|---|---|---|---|
| Stock Price ($) | 25.50 | 13.17 | -48.4% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 2,637 | 1,002 | -62.0% |
| P/S Multiple | 0.3 | 0.4 | 19.3% |
| Shares Outstanding (Mil) | 36 | 31 | 14.0% |
| Cumulative Contribution | -48.4% |
Market Drivers
5/31/2023 to 6/20/2026| Return | Correlation | |
|---|---|---|
| CCRN | -48.4% | |
| Market (SPY) | 85.7% | 10.8% |
| Sector (XLV) | 22.9% | 5.3% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| CCRN Return | 213% | -4% | -15% | -20% | -55% | 63% | 48% |
| Peers Return | 60% | -14% | 8% | -17% | -22% | 26% | 22% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 8% | 98% |
Monthly Win Rates [3] | |||||||
| CCRN Win Rate | 67% | 42% | 33% | 25% | 25% | 83% | |
| Peers Win Rate | 73% | 43% | 50% | 40% | 43% | 63% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | |
Max Drawdowns [4] | |||||||
| CCRN Max Drawdown | -17% | -44% | -42% | -58% | -59% | -15% | |
| Peers Max Drawdown | -18% | -33% | -27% | -34% | -42% | -33% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: AMN, ENSG, KFY, RHI, NSP.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 6/18/2026 (YTD)
How Low Can It Go
| Event | CCRN | S&P 500 |
|---|---|---|
| 2023 SVB Regional Banking Crisis | ||
| % Loss | -18.6% | -6.7% |
| % Gain to Breakeven | 22.9% | 7.1% |
| Time to Breakeven | 31 days | 31 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -43.5% | -24.5% |
| % Gain to Breakeven | 77.1% | 32.4% |
| Time to Breakeven | 66 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -45.2% | -33.7% |
| % Gain to Breakeven | 82.3% | 50.9% |
| Time to Breakeven | 310 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -15.1% | -19.2% |
| % Gain to Breakeven | 17.8% | 23.8% |
| Time to Breakeven | 20 days | 105 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -24.4% | -12.2% |
| % Gain to Breakeven | 32.2% | 13.9% |
| Time to Breakeven | 60 days | 62 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -47.7% | -17.9% |
| % Gain to Breakeven | 91.0% | 21.8% |
| Time to Breakeven | 788 days | 123 days |
In The Past
Cross Country Healthcare's stock fell 0.0% during the 2024 Yen Carry Trade Unwind. Such a loss loss requires a 0.0% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | CCRN | S&P 500 |
|---|---|---|
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -43.5% | -24.5% |
| % Gain to Breakeven | 77.1% | 32.4% |
| Time to Breakeven | 66 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -45.2% | -33.7% |
| % Gain to Breakeven | 82.3% | 50.9% |
| Time to Breakeven | 310 days | 140 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -24.4% | -12.2% |
| % Gain to Breakeven | 32.2% | 13.9% |
| Time to Breakeven | 60 days | 62 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -47.7% | -17.9% |
| % Gain to Breakeven | 91.0% | 21.8% |
| Time to Breakeven | 788 days | 123 days |
| 2010 Eurozone Sovereign Debt Crisis / Flash Crash | ||
| % Loss | -26.3% | -15.4% |
| % Gain to Breakeven | 35.8% | 18.2% |
| Time to Breakeven | 1304 days | 125 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -64.3% | -53.4% |
| % Gain to Breakeven | 179.8% | 114.4% |
| Time to Breakeven | 2353 days | 1085 days |
In The Past
Cross Country Healthcare's stock fell 0.0% during the 2024 Yen Carry Trade Unwind. Such a loss loss requires a 0.0% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Cross Country Healthcare (CCRN)
Cross Country Healthcare, Inc. (CCRN) is a prominent provider of talent management and staffing solutions for the United States healthcare sector. The company's core business revolves around addressing the critical need for qualified medical professionals by connecting healthcare organizations with the talent they require. Essentially, CCRN functions as a vital partner for healthcare clients seeking to fill staffing gaps and optimize their workforce.
The company operates through two primary segments, offering a comprehensive suite of services. Its Nurse and Allied Staffing segment provides temporary and permanent placement of travel nurses, local nurses, allied health professionals, and pharmacists. This segment also offers workforce solutions such as Managed Service Provider (MSP) programs and Recruitment Process Outsourcing (RPO). The Physician Staffing segment, branded as Cross Country Locums, specializes in placing physicians across various specialties, certified registered nurse anesthetists (CRNAs), nurse practitioners, and physician assistants on temporary assignments.
CCRN serves a broad and diverse client base throughout the nation. Its primary customers include public and private acute and non-acute care hospitals, government facilities, local and national healthcare plans, and managed care providers. Additionally, the company provides essential staffing support to public and charter schools, outpatient clinics, ambulatory care facilities, and physician practice groups, ensuring these healthcare and educational entities can maintain their operations effectively.
AI Analysis | Feedback
It's essentially a **temp agency for hospitals and clinics**.
AI Analysis | Feedback
- Nurse and Allied Professional Staffing: Provides temporary and permanent placement of nurses and allied health professionals for various healthcare settings.
- Physician and Advanced Practice Staffing: Offers temporary (locum tenens) assignments for physicians, certified registered nurse anesthetists, nurse practitioners, and physician assistants.
- Workforce Solutions: Delivers managed service programs (MSP), recruitment process outsourcing (RPO), and consulting services to healthcare clients.
- Retained and Contingent Search Services: Conducts executive and professional search for healthcare professionals on a retained or contingent basis.
AI Analysis | Feedback
- Public and private acute care and non-acute care hospitals
- Government facilities
- Local and national healthcare plans, managed care providers, and managed care organizations
- Public and charter schools
- Outpatient clinics, ambulatory care facilities, physician practice groups, and medical group practices
- Other healthcare providers
AI Analysis | Feedback
AI Analysis | Feedback
Kevin C. Clark, Co-Founder, Chairman, and Chief Executive Officer
Kevin C. Clark co-founded Cross Country Healthcare in 1986, helping to pioneer the modern healthcare staffing industry. He served as Chairman and Chief Executive Officer through 1994, and again from January 2019 to March 2022. He returned as President and Chief Executive Officer, effective December 14, 2025. Between his tenures at Cross Country Healthcare, he co-founded OGH, LLC, a leading workforce solutions company that was acquired by AMN Healthcare in 2015. He also founded or led other healthcare staffing companies such as Talivity, Inc., Onward Healthcare, Inc., Locum Leaders, and Medefis, all of which were acquired in 2015. Additionally, Mr. Clark led Pinnacor Inc., which had a successful IPO in 2000 and was later sold to Dow Jones & Co.
William J. Burns, Executive Vice President and Chief Financial Officer
William J. Burns has served as the Executive Vice President and Chief Financial Officer of Cross Country Healthcare since 2022. He joined the company in April 2014. Prior to joining Cross Country Healthcare, Mr. Burns was the Group Vice President and Corporate Controller for Gartner, Inc. His career spans nearly three decades, with senior executive roles at companies including Computer Associates, Adecco, and Honeywell. He was recognized with the South Florida Business Journal CFO Award for Turn-Around Achievement of the Year in 2016 for his work with Cross Country.
Daniel J. White, Chief Commercial Officer
Daniel J. White joined Cross Country Healthcare as its first Chief Commercial Officer in April 2022. He brings over 25 years of experience in the staffing industry and is recognized as an expert in Total Workforce Management. Before his role at Cross Country Healthcare, Mr. White held senior leadership positions including President of Workforce Solutions at AMN Healthcare Services, Inc., President of Recruitment Process Outsourcing at Pontoon Solutions, and Global Offering Leader for Smarter Workforce Services at IBM Corporation. Most recently, he served as CEO of Healthcareteams.
Susan E. Ball, Executive Vice President, Chief Administrative Officer, General Counsel and Secretary
Susan E. Ball joined Cross Country Healthcare in 2002 and has served as General Counsel since May 2004, and Secretary since March 2010. She was appointed Executive Vice President on January 1, 2017, and also holds the title of Chief Administrative Officer. Before practicing law, Ms. Ball was a Registered Nurse, which provides her with unique insight into the company's legal matters. She previously practiced law at Gunster, a Florida-based law firm, and Skadden, Arps, Slate, Meagher and Flom in New York.
Marvin Veizaga, Senior Vice President, Chief Accounting Officer
Marvin Veizaga was appointed Senior Vice President, Chief Accounting Officer, effective March 10, 2026. He has been with Cross Country Healthcare since 2015, previously serving as Group Vice President, Corporate Controller, Vice President, Assistant Controller, and Vice President, Business Unit Controller. Before joining the company, Mr. Veizaga was a Senior Auditor at Deloitte & Touche LLP. He is a certified public accountant.
AI Analysis | Feedback
The key risks to Cross Country Healthcare (CCRN) are primarily centered around the challenging dynamics of the healthcare labor market and the execution of strategic transactions.
- Shortage and Retention of Qualified Healthcare Professionals: Cross Country Healthcare's core business relies heavily on its ability to recruit and retain qualified nurses, allied professionals, and physicians. The healthcare industry is facing a widespread and persistent shortage of skilled professionals, exacerbated by an aging workforce nearing retirement, insufficient growth in nursing school enrollments, and high rates of burnout and attrition among existing staff. This shortage directly impacts the company's ability to fill client assignments and meet growing patient demand, posing a fundamental threat to its revenue and operational stability.
- Fluctuations in Demand for Healthcare Staffing Services: The demand for temporary healthcare labor, particularly travel nursing, has seen significant post-pandemic normalization, leading to a market pullback. Cross Country Healthcare's Nurse and Allied segment experienced a substantial year-over-year revenue decline in Q1 2025, indicating challenges in this core market. Healthcare facilities are increasingly seeking to optimize labor deployment and reduce reliance on premium temporary staffing, which can impact the volume and pricing of services offered by staffing companies like CCRN.
- Risks Associated with Acquisitions and Strategic Transactions: Cross Country Healthcare continually evaluates and pursues acquisitions and strategic transactions for growth. However, such activities inherently carry execution and regulatory risks, as demonstrated by the recently terminated agreement for its acquisition by Aya Healthcare. This specific event resulted in financial exposure for CCRN, including a $20.0 million termination fee, and highlights potential adverse impacts on its business, operations, and financial condition from unrecovered transaction costs, integration challenges, and regulatory scrutiny in future strategic endeavors.
AI Analysis | Feedback
AI Analysis | Feedback
AI Analysis | Feedback
Cross Country Healthcare (CCRN) is expected to drive future revenue growth over the next 2-3 years through several key initiatives and market improvements:
- Technology-Led Growth through Proprietary Platforms and Automation: The company is leveraging its proprietary technology platforms, Intellify and Xperience, as central to its future growth strategy. Intellify is planned for expansion into the home-based and education staffing markets in 2026, and 95% of Managed Service Provider (MSP) and vendor-neutral clients are already utilizing it. Cross Country Healthcare is also integrating AI and automation to enhance recruiter productivity, improve efficiency, expand margins, and establish scalable recurring revenue streams.
- Strategic Investments in Revenue Producers: Cross Country Healthcare has made deliberate investments in increasing its revenue-generating staff, including recruiters, account managers, and sales professionals. These investments, primarily funded by redeploying cost savings, have already shown positive results, with several dozen new revenue producers added in the first quarter of 2026.
- Expansion and Growth in Higher-Margin and Strategic Segments: The company is focusing on and experiencing growth in its higher-margin and strategic segments. The Physician Staffing segment demonstrated strong top-line growth in Q4 2023, increasing 26% year-over-year. The home-based staffing business also saw robust organic growth, up 34% over the prior year in Q4 2025. Additionally, the Education Staffing business is projected to return to growth in 2026, with these diversified segments contributing to stability and incremental growth.
- Stabilization and Recovery of the Travel Nursing and Allied Staffing Market, Coupled with New Client Acquisitions and MSP Wins: Management anticipates a stabilization and recovery in the healthcare staffing market, particularly in travel nursing, with an expectation for growth in 2026. There is noted stability in demand and bill rates, and clients are increasingly prioritizing the speed of filling positions. The company expects travel assignments to be flat to slightly up sequentially, with Travelers On Assignment projected to grow monthly into Q2 2026. Furthermore, Cross Country Healthcare successfully renewed, expanded, and secured over $400 million in new contract value, predominantly with its MSP clients, and possesses a robust sales pipeline for expanding its portfolio and acquiring new clients in 2026.
AI Analysis | Feedback
Share Repurchases
- Cross Country Healthcare's Board of Directors authorized a new $100 million stock repurchase program in August 2022.
- In December 2025, following the termination of its planned merger with Aya Healthcare, the company announced it would immediately commence repurchases under an existing $40 million authorization.
- From October 1 to December 31, 2025, the company repurchased 800,000 shares for $6.5 million. As of December 31, 2025, $34.0 million remained authorized for future repurchases.
Share Issuance
- Cross Country Healthcare reported $0 million in issuance of stock as of September and December 2025.
Inbound Investments
- In December 2024, Aya Healthcare announced a definitive agreement to acquire Cross Country Healthcare in an all-cash deal valued at approximately $615 million, or $18.61 per share.
- This merger agreement was terminated in December 2025 due to regulatory scrutiny.
- Upon termination of the merger, Aya Healthcare paid Cross Country Healthcare a $20 million fee.
Outbound Investments
- In June 2021, Cross Country Healthcare acquired Workforce Solutions Group, Inc. (WSG) for $25.0 million in cash and $5.0 million in company common stock, with a potential earn-out of up to an additional $15.0 million. This acquisition aimed to expand its home care business.
Capital Expenditures
- Annual capital expenditures were approximately $8.79 million in 2022, $14 million in 2023, and $8.71 million in 2024.
- For the trailing twelve months ended September 2025, capital expenditure was -$8.58 million.
- The company is focusing capital on expanding its proprietary technology platform, Intellify®, into home-based and education staffing markets in 2026.
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 33.91 |
| Mkt Cap | 2.3 |
| Rev LTM | 4,347 |
| Op Inc LTM | 106 |
| FCF LTM | 217 |
| FCF 3Y Avg | 236 |
| CFO LTM | 320 |
| CFO 3Y Avg | 368 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 4.2% |
| Rev Chg 3Y Avg | -4.1% |
| Rev Chg Q | 4.4% |
| QoQ Delta Rev Chg LTM | 1.1% |
| Op Inc Chg LTM | -26.7% |
| Op Inc Chg 3Y Avg | -38.3% |
| Op Mgn LTM | 2.7% |
| Op Mgn 3Y Avg | 4.4% |
| QoQ Delta Op Mgn LTM | 0.0% |
| CFO/Rev LTM | 8.1% |
| CFO/Rev 3Y Avg | 9.2% |
| FCF/Rev LTM | 4.1% |
| FCF/Rev 3Y Avg | 6.9% |
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Nurse and Allied Staffing | 863 | 1,145 | 1,841 | 2,700 | 1,606 |
| Physician Staffing | 192 | 199 | 178 | 106 | 71 |
| Total | 1,054 | 1,344 | 2,020 | 2,807 | 1,677 |
| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Nurse and Allied Staffing | 58 | 73 | 197 | 355 | 206 |
| Physician Staffing | 16 | 15 | 10 | 6 | 4 |
| Acquisition and integration-related costs | 3 | -4 | -0 | ||
| Legal and other losses | -3 | -7 | -1 | ||
| Restructuring costs | -4 | -4 | -3 | -2 | -3 |
| Depreciation and amortization | -17 | -18 | -18 | -13 | -10 |
| Corporate overhead | -61 | -69 | -71 | -67 | -55 |
| Impairment charges | -78 | -3 | -1 | -6 | -2 |
| Legal settlement charges | 0 | ||||
| Other costs | -1 | -1 | |||
| Total | -84 | -17 | 113 | 273 | 139 |
Price Behavior
| Market Price | $13.17 | |
| Market Cap ($ Bil) | 0.4 | |
| First Trading Date | 10/25/2001 | |
| Distance from 52W High | -7.4% | |
| 50 Days | 200 Days | |
| DMA Price | $11.89 | $10.78 |
| DMA Trend | indeterminate | up |
| Distance from DMA | 10.8% | 22.1% |
| 3M | 1YR | |
| Volatility | 64.1% | 55.8% |
| Downside Capture | -154.93 | 43.48 |
| Upside Capture | 39.10 | 23.90 |
| Correlation (SPY) | -3.5% | 15.0% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | -2.84 | -1.46 | -0.21 | 0.34 | 0.74 | 0.44 |
| Up Beta | -2.14 | -1.42 | -0.96 | -0.28 | 0.16 | 0.13 |
| Down Beta | 2.49 | 1.26 | 2.33 | 1.88 | 2.22 | 0.50 |
| Up Capture | -7% | 35% | 44% | 33% | 24% | 12% |
| Bmk +ve Days | 13 | 28 | 36 | 67 | 141 | 432 |
| Stock +ve Days | 9 | 21 | 30 | 61 | 118 | 352 |
| Down Capture | -1093% | -650% | -206% | -31% | 55% | 92% |
| Bmk -ve Days | 7 | 13 | 27 | 57 | 109 | 318 |
| Stock -ve Days | 5 | 14 | 27 | 57 | 122 | 378 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CCRN | |
|---|---|---|---|---|
| CCRN | -3.1% | 55.7% | 0.14 | - |
| Sector ETF (XLV) | 14.0% | 15.0% | 0.66 | 2.3% |
| Equity (SPY) | 26.5% | 12.4% | 1.61 | 14.7% |
| Gold (GLD) | 24.2% | 27.5% | 0.77 | -1.0% |
| Commodities (DBC) | 19.8% | 18.8% | 0.83 | 6.5% |
| Real Estate (VNQ) | 11.0% | 13.7% | 0.52 | 6.1% |
| Bitcoin (BTCUSD) | -40.0% | 42.5% | -1.08 | 7.1% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CCRN | |
|---|---|---|---|---|
| CCRN | -4.6% | 60.0% | 0.14 | - |
| Sector ETF (XLV) | 5.4% | 14.7% | 0.19 | 15.4% |
| Equity (SPY) | 13.5% | 17.1% | 0.62 | 21.1% |
| Gold (GLD) | 17.1% | 18.3% | 0.76 | -1.7% |
| Commodities (DBC) | 7.5% | 19.4% | 0.29 | 1.0% |
| Real Estate (VNQ) | 1.9% | 18.9% | 0.00 | 16.7% |
| Bitcoin (BTCUSD) | 11.0% | 54.2% | 0.40 | 10.6% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with CCRN | |
|---|---|---|---|---|
| CCRN | -0.6% | 56.8% | 0.22 | - |
| Sector ETF (XLV) | 9.4% | 16.6% | 0.46 | 24.7% |
| Equity (SPY) | 15.3% | 18.0% | 0.73 | 29.4% |
| Gold (GLD) | 12.3% | 16.1% | 0.63 | -1.1% |
| Commodities (DBC) | 5.9% | 18.0% | 0.26 | 6.7% |
| Real Estate (VNQ) | 5.3% | 20.7% | 0.22 | 23.6% |
| Bitcoin (BTCUSD) | 60.0% | 66.8% | 1.00 | 8.4% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Updated 6/10/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 5/7/2026 | 0.7% | 0.3% | 0.7% |
| 3/4/2026 | 8.3% | 7.1% | 0.5% |
| 11/12/2025 | -14.1% | -8.8% | -34.8% |
| 8/6/2025 | -4.4% | 0.1% | 7.6% |
| 5/7/2025 | 0.4% | 1.1% | -6.7% |
| 3/5/2025 | -6.3% | -5.8% | -12.0% |
| 11/6/2024 | 1.0% | -16.9% | 48.8% |
| 7/31/2024 | -3.8% | -13.7% | -17.2% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 13 | 13 | 14 |
| # Negative | 11 | 11 | 10 |
| Median Positive | 4.9% | 9.9% | 14.7% |
| Median Negative | -6.4% | -8.8% | -11.2% |
| Max Positive | 24.7% | 17.1% | 48.8% |
| Max Negative | -17.0% | -19.4% | -34.8% |
| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 5/7/2026 | 0.7% | 0.3% | 0.7% |
| 3/4/2026 | 8.3% | 7.1% | 0.5% |
| 11/12/2025 | -14.1% | -8.8% | -34.8% |
| 8/6/2025 | -4.4% | 0.1% | 7.6% |
| 5/7/2025 | 0.4% | 1.1% | -6.7% |
| 3/5/2025 | -6.3% | -5.8% | -12.0% |
| 11/6/2024 | 1.0% | -16.9% | 48.8% |
| 7/31/2024 | -3.8% | -13.7% | -17.2% |
| 5/1/2024 | -6.5% | -8.0% | -15.5% |
| 2/21/2024 | -0.2% | 9.9% | 10.4% |
| 11/1/2023 | -13.8% | -19.4% | -10.4% |
| 8/2/2023 | -17.0% | -12.2% | -2.8% |
| 5/3/2023 | 4.8% | 13.3% | 25.7% |
| 2/22/2023 | -6.4% | 0.5% | -13.8% |
| 11/2/2022 | 4.9% | -5.2% | 4.5% |
| 9/14/2022 | 8.1% | 11.2% | 21.1% |
| 5/4/2022 | -8.5% | -17.4% | -5.2% |
| 2/23/2022 | -1.8% | 6.1% | 3.6% |
| 11/3/2021 | 20.0% | 12.6% | 16.7% |
| 8/4/2021 | 24.7% | 17.1% | 29.3% |
| 5/5/2021 | 13.5% | 11.3% | 14.4% |
| 2/24/2021 | 12.5% | 17.1% | 21.8% |
| 11/4/2020 | 0.0% | -2.0% | 15.0% |
| 8/5/2020 | 4.9% | -3.1% | -2.4% |
| SUMMARY STATS | |||
| # Positive | 13 | 13 | 14 |
| # Negative | 11 | 11 | 10 |
| Median Positive | 4.9% | 9.9% | 14.7% |
| Median Negative | -6.4% | -8.8% | -11.2% |
| Max Positive | 24.7% | 17.1% | 48.8% |
| Max Negative | -17.0% | -19.4% | -34.8% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 03/31/2026 | 05/08/2026 | 10-Q |
| 12/31/2025 | 03/09/2026 | 10-K |
| 09/30/2025 | 11/12/2025 | 10-Q |
| 06/30/2025 | 08/06/2025 | 10-Q |
| 03/31/2025 | 05/07/2025 | 10-Q |
| 12/31/2024 | 03/05/2025 | 10-K |
| 09/30/2024 | 11/07/2024 | 10-Q |
| 06/30/2024 | 08/01/2024 | 10-Q |
| 03/31/2024 | 05/02/2024 | 10-Q |
| 12/31/2023 | 02/23/2024 | 10-K |
| 09/30/2023 | 11/02/2023 | 10-Q |
| 06/30/2023 | 08/03/2023 | 10-Q |
| 03/31/2023 | 05/04/2023 | 10-Q |
| 12/31/2022 | 02/23/2023 | 10-K |
| 09/30/2022 | 11/03/2022 | 10-Q |
| 06/30/2022 | 08/04/2022 | 10-Q |
| Report Date | Filing Date | Filing |
|---|---|---|
| 03/31/2026 | 05/08/2026 | 10-Q |
| 12/31/2025 | 03/09/2026 | 10-K |
| 09/30/2025 | 11/12/2025 | 10-Q |
| 06/30/2025 | 08/06/2025 | 10-Q |
| 03/31/2025 | 05/07/2025 | 10-Q |
| 12/31/2024 | 03/05/2025 | 10-K |
| 09/30/2024 | 11/07/2024 | 10-Q |
| 06/30/2024 | 08/01/2024 | 10-Q |
| 03/31/2024 | 05/02/2024 | 10-Q |
| 12/31/2023 | 02/23/2024 | 10-K |
| 09/30/2023 | 11/02/2023 | 10-Q |
| 06/30/2023 | 08/03/2023 | 10-Q |
| 03/31/2023 | 05/04/2023 | 10-Q |
| 12/31/2022 | 02/23/2023 | 10-K |
| 09/30/2022 | 11/03/2022 | 10-Q |
| 06/30/2022 | 08/04/2022 | 10-Q |
| 03/31/2022 | 05/05/2022 | 10-Q |
| 12/31/2021 | 02/28/2022 | 10-K |
| 09/30/2021 | 11/04/2021 | 10-Q |
| 06/30/2021 | 08/05/2021 | 10-Q |
| 03/31/2021 | 05/06/2021 | 10-Q |
| 12/31/2020 | 02/25/2021 | 10-K |
| 09/30/2020 | 11/05/2020 | 10-Q |
| 06/30/2020 | 08/06/2020 | 10-Q |
| 03/31/2020 | 05/08/2020 | 10-Q |
| 12/31/2019 | 03/05/2020 | 10-K |
| 09/30/2019 | 11/06/2019 | 10-Q |
| 06/30/2019 | 08/01/2019 | 10-Q |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.